Parasites, Hosts and Diseases

The Korea Society for Parasitology and Tropical Medicine (대한기생충학·열대의학회)
권호 표지
DOI QR코드

DOI QR Code

Immunopathological Changes in the Brain of Immunosuppressed Mice Experimentally Infected with Toxocara canis

  • Eid, Mohamed M. (Department of Medical Parasitology, Faculty of Medicine, Tanta University) ;
  • El-Kowrany, Samy I. (Department of Medical Parasitology, Faculty of Medicine, Tanta University) ;
  • Othman, Ahmad A. (Department of Medical Parasitology, Faculty of Medicine, Tanta University) ;
  • El Gendy, Dina I. (Department of Medical Parasitology, Faculty of Medicine, Tanta University) ;
  • Saied, Eman M. (Department of Pathology, Faculty of Medicine, Kafr El-Sheikh University)
  • Received : 2014.05.23
  • Accepted : 2014.10.20
  • Published : 2015.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Toxocariasis is a soil-transmitted helminthozoonosis due to infection of humans by larvae of Toxocara canis. The disease could produce cognitive and behavioral disturbances especially in children. Meanwhile, in our modern era, the incidence of immunosuppression has been progressively increasing due to increased incidence of malignancy as well as increased use of immunosuppressive agents. The present study aimed at comparing some of the pathological and immunological alterations in the brain of normal and immunosuppressed mice experimentally infected with T. canis. Therefore, 180 Swiss albino mice were divided into 4 groups including normal (control) group, immunocompetent T. canis-infected group, immunosuppressed group (control), and immunosuppressed infected group. Infected mice were subjected to larval counts in the brain, and the brains from all mice were assessed for histopathological changes, astrogliosis, and IL-5 mRNA expression levels in brain tissues. The results showed that under immunosuppression, there were significant increase in brain larval counts, significant enhancement of reactive gliosis, and significant reduction in IL-5 mRNA expression. All these changes were maximal in the chronic stage of infection. In conclusion, the immunopathological alterations in the brains of infected animals were progressive over time, and were exaggerated under the effect of immunosuppression as did the intensity of cerebral infection.

Keywords

References

  1. Fillaux J, Magnaval JF. Laboratory diagnosis of human toxocariasis. Vet Parasitol 2013; 193: 327-336. https://doi.org/10.1016/j.vetpar.2012.12.028
  2. Finsterer J, Auer H. Neurotoxocarosis. Rev Inst Med Trop Sao Paulo 2007; 49: 279-287. https://doi.org/10.1590/S0036-46652007000500002
  3. Taylor MR, Keane CT, O'Connor P, Mulvihill E, Holland C. The expanded spectrum of toxocaral disease. Lancet 1988; 1: 692-695.
  4. Barsoum RS. Parasitic infections in transplant recipients. Nat Rev Nephrol 2006; 2: 490-503. https://doi.org/10.1038/ncpneph0255
  5. Stark D, Barratt JL, van Hal S, Marriott D, Harkness J, Ellis JT. Clinical significance of enteric protozoa in the immunosuppressed human population. Clin Microbiol Rev 2009; 22: 634-650. https://doi.org/10.1128/CMR.00017-09
  6. Derouin F. Parasitic infection in immunocompromised patients. La Revue du Praticien (Rev Prat) 2007; 57: 167-173 (in French).
  7. Goettsch W, Garssen J, De Gruijl FR, Van Loveren H. UVB-induced decreased resistance to Trichinella spiralis in the rats is related to impaired cellular immunity. Photochem Photobiol 1996; 46: 581-585.
  8. Faz-Lopez B, Ledesma-Soto Y, Romero-Sanchez Y, Calleja E, Martinez-Labat P, Terrazas LI. Signal transducer and activator of transcription factor 6 signaling contributes to control host lung pathology but favors susceptibility against Toxocara canis infection. Biomed Res Int 2013; 2013: 696343.
  9. Abo El-Asaad IA, Eid MM, El-Marhoumy SM, Eissa TM. The effect of immunosuppression on the course of experimental toxocariasis (immunological and histopathological study). New Egypt J Med 1994; 11: 165-170.
  10. Al-Nuaimy WM, Saeed LG, Al-Hafidh HA. The role of glial fibrillary acidic protein (GFAP) in the diagnosis of neuroepithelial tumors. Jordan Med J 2010; 4: 466-475.
  11. Nutt CL, Betensky RA, Brower MA, Batchelor TT, Louis DN, Stemmer-Rachamimov AO. YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas. Clin Cancer Res 2005; 11: 2258-2264. https://doi.org/10.1158/1078-0432.CCR-04-1601
  12. Holland CV, Hamilton CM. The significance of cerebral toxocariasis: a model system for exploring the link between brain involvement, behaviour and the immune response. J Exp Biol 2013; 216: 78-83. https://doi.org/10.1242/jeb.074120
  13. el-Ridi AM, Abou-Ragab HA, Ismail MM, Shehata MM, Ramadan ME, Etwa SE. Effect of some drugs on some histopathological and immunological aspects of experimental trichinosis in albino rats. J Eygpt Soc Parasitol 1990; 20: 99-104.
  14. Mariotti J, Taylor J, Massey PR, Ryan K, Foley J, Buxhoeveden N, Felizardo TC, Amarnath S, Mossoba ME, Fowler DH. The pentostatin plus cyclophosphamide non-myeloablative regimen induces durable host T-cell functional deficits and prevents murine marrow allograft rejection. Biol Blood Marrow Transplant 2011; 17: 620-631. https://doi.org/10.1016/j.bbmt.2010.11.029
  15. Sanad MM, Al-Furaeihi LM. Effect of some immunomodulators on the host-parasite system in experimental hymenolepiasis nana. J Egypt Soc Parasitol 2006; 36: 65-80.
  16. El-Kowrany SE, Abd-El-Ghaffar AE, Ghoraba HM. Experimental heterophyiasis. The effect of immunosuppression on the course of the disease. Egypt J Med Sci 1996; 17: 481-497.
  17. Budovsky A, Prinsloo I, El-On J. Pathological developments mediated by cyclophosphamide in rats infected with Trypanosoma lewisi. Parasitol Int 2006; 55: 237-242. https://doi.org/10.1016/j.parint.2006.06.001
  18. Liao CW, Cho WL, Kao TC, Su KE, Lin YH, Fan CK. Blood-brain barrier impairment with enhanced SP, NK-1R, GFAP and claudin-5 expressions in experimental cerebral toxocariasis. Parasite Immunol 2008; 30: 525-534. https://doi.org/10.1111/j.1365-3024.2008.01048.x
  19. Othman AA, Abdel-Aleem GA, Saied EM, Mayah WW, Elatrash AM. Biochemical and immunopathological changes in experimental neurotoxocariasis. Mol Biochem Parasitol 2010; 172: 1-8. https://doi.org/10.1016/j.molbiopara.2010.03.006
  20. Eid MM. Immunopathological study on the brain in mice experimentally infected with Schistosoma mansoni. M.Sc. Thesis. Tropical Medicine Department, Faculty of Medicine, Tanta University, Egypt. 1994.
  21. James P, Emma E, Jon G. Monitoring reactive gliosis in 3-dimentional astrocyte cultures; a model of spinal cord damage. In Neuroscience 2008, the 38th annual meeting of the Society for Neuroscience. 2008. pp 9-15.
  22. Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW. Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem 2004; 89: 1092-1100. https://doi.org/10.1111/j.1471-4159.2004.02420.x
  23. Stein ML, Munitz A. Targeting interleukin (IL) 5 for asthma and hypereosinophilic diseases. Recent Pat Inflamm Allergy Drug Discov 2010; 4: 201-209. https://doi.org/10.2174/187221310793564290
  24. Yamaguchi Y, Matsui T, Kasahara T, Etoh S, Tominaga A, Takatsu K, Miura Y, Suda T. In vivo changes of hemopoitic progenitors and the expression of interleukin 5 gene in eosinophilic mice infected with Toxocara canis. Exp Hematol 1990; 18: 1152-1157.
  25. Hamilton CM, Brandes S, Holland CV, Pinelli E. Cytokine expression in the brains of Toxocara canis-infected mice. Parasite Immunol 2008; 30: 181-185. https://doi.org/10.1111/j.1365-3024.2007.01002.x

Cited by

  1. Seroprevalence and Risk Factors for Toxocara canis Infection in Serbia During 2015 vol.14, pp.1, 2015, https://doi.org/10.1089/fpd.2016.2190
  2. Histopathological characterization of Toxocara canis- and T. cati-induced neurotoxocarosis in the mouse model vol.118, pp.9, 2019, https://doi.org/10.1007/s00436-019-06395-7
  3. Diallyl sulfide alleviates cyclophosphamide-induced nephropathic encephalopathy in rats vol.30, pp.3, 2015, https://doi.org/10.1080/15376516.2019.1695991
  4. Mesenchymal stem cells combined with albendazole as a novel therapeutic approach for experimental neurotoxocariasis vol.147, pp.7, 2020, https://doi.org/10.1017/s003118202000044x